Echocardiography, commonly referred to as cardiac ultrasound or an “echo”, generates visual images of the heart known as echocardiograms. This imaging technique is especially informative during the peripartum period, the time encompassing before, during, and immediately after pregnancy. Preeclampsia is associated with an increased risk of cardiovascular disease which can show up in an echo.
A study conducted at NYU Langone Hospital aimed to assess the impact of routine postpartum echocardiograms on the management of patients diagnosed with severe preeclampsia. Researchers compared two groups: those who received echocardiograms after delivery and those who did not. The researchers wanted to see if having an echocardiogram affected hospital stay length, use of diuretics, adjustments in antihypertensive medication, and readmission rates.
The study included 356 patients, with 145 undergoing postpartum echocardiograms. Findings showed that patients who received echocardiograms had longer hospital stays (median of 5 days compared to 4), were more likely to receive diuretics, and had increased adjustments in their antihypertensive medication dosage. These patients were also more likely to be readmitted.
Further analysis within the echocardiogram group revealed that those with abnormal echo results experienced even longer hospital stays and a greater likelihood of receiving diuretics. However, there was no significant difference in the adjustment of antihypertensive medications or readmission rates between those with normal and abnormal echo results.
The study suggests that echocardiograms are often ordered for patients displaying more severe symptoms of preeclampsia, rather than the echocardiograms themselves prompting changes in management.
Take Home Message: The results indicate that postpartum echocardiograms can help identify patients with severe preeclampsia who may benefit from more intensive management strategies. Future research is encouraged to focus on detailed analyses of cardiac structure and function in these patients, which would require a larger sample size to enhance findings.
Link: https://www.ajog.org/article/S0002-9378(24)00450-2/pdf
Citation: Kantorowska, A., Corbo, A. M., Akerman, M. B., Gubernikoff, G., Kinzler, W. L., Vintzileos, A. M., & Rekawek, P. (2024). The value of maternal echocardiography after delivery in patients with severe preeclampsia. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2024.03.021
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
While the foundations of preeclampsia are believed to develop in the early stages of pregnancy, the current screening process occurs at 20 weeks, nearly half way through the second trimester. When cli...
Research suggests that preeclampsia may develop in a two-stage process. The first stage involves challenges to the way that the placenta implants and grows. In a normal pregnancy, a type of placental...
The risk of developing hypertension and cardiovascular disease (CVD) significantly increases for patients who experience gestational hypertension, preeclampsia, or other hypertensive disorders of preg...
Cerebral complications from preeclampsia and eclampsia are a major cause of maternal mortality and long-term neurological impact. Understanding pathophysiology (changes in how the body works as a resu...
The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia research. The ultimate goal of this grant prog...